Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
April 10, 2025 16:05 ET | Source: Avadel Pharmaceuticals plc DUBLIN, April…
Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients withAcquired Hypothalamic Obesity
Company to host conference call on April 7 at 8 a.m. ET…
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq:…
AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal
OCALA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (“AIM”…
Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
STAFFORD, Texas, April 02, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq:…
AGC Biologics Forms Dedicated Cell and Gene Technologies Division, Designed to Build Upon Their Track Record of Nine Commercially Approved Products to Date
Luca Alberici appointed to lead new Division offering focused technical innovation, product…
Candel Therapeutics Announces Publication of Phase 1b Clinical Trial Data on the Combination of CAN-2409 and Nivolumab plus Standard of Care in Newly Diagnosed High-Grade Glioma Patients
Data published in Neuro-Oncology demonstrate promising safety profile and potential survival benefit…
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone”…
Resolutions from Zealand Pharma’s Annual General Meeting 2025
Company announcement – No. 7 / 2025 Resolutions from Zealand Pharma's Annual…
Vantage as a Platinum Partner of AIESEC FHN in Vietnam
PORT VILA, Vanuatu, March 25, 2025 /PRNewswire/ -- Vantage reflects on its collaboration…
